Why Atrial Fibrillation Ablation Should Be Considered First-Line Therapy for Some Patients
- 23 August 2005
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation
- Vol. 112 (8) , 1214-1230
- https://doi.org/10.1161/circulationaha.104.478263
Abstract
Atrial fibrillation (AF) is an increasingly common disease that affects patient morbidity and mortality. To date, treatments of AF have been frustrating, serving at best to palliate this arrhythmia. AF ablation, on the other hand, has emerged as a promising new treatment strategy. In contrast to rate control or antiarrhythmic drugs, ablation offers the possibility of a lasting cure. When ablation was first described, it was prudently reserved as a “last-line” treatment for highly symptomatic patients who were refractory to all other options. However, over the past 5 years, many centers worldwide have been reporting high success rates and few complications with ablation. There is also an increasing consistency in the way in which the procedure is performed, although some of the tools may still differ. AF ablation has reached “prime time,” and it appears appropriate that we expand its indications. We believe that it is now appropriate to offer AF ablation as first-line therapy for selected patients in experienced centers. Here, we stress the importance of maintaining sinus rhythm, the poor efficacy of nonablative treatments, and the emergence of an effective and safe approach to AF ablation. Recently, the importance of maintaining sinus rhythm has been called into question. A few large clinical trials have been published comparing treatment strategies for AF. In particular, the AF Follow-up Investigation of Rhythm Management (AFFIRM),1 Rate Control Versus Electrical Cardioversion for AF (RACE),2 and Strategies for Treatment of AF (STAF)3 trials compared a strategy of rate control and a rhythm control approach using antiarrhythmic drugs. Using an intention-to-treat analysis, these trials concluded that there was no mortality difference between the 2 approaches and that, for the patients enrolled, a rate control approach may be adequate treatment for AF. However, it would be incorrect to extrapolate that sinus rhythm offers …Keywords
This publication has 50 references indexed in Scilit:
- Atrio-Esophageal Fistula as a Complication of Percutaneous Transcatheter Ablation of Atrial FibrillationCirculation, 2004
- Pulmonary vein antrum isolation for treatment of atrial fibrillation in patients with valvular heart disease or prior open heart surgeryHeart Rhythm, 2004
- Incremental Value of Isolating the Right Inferior Pulmonary Vein During Pulmonary Vein Isolation Procedures in Patients With Paroxysmal Atrial FibrillationPacing and Clinical Electrophysiology, 2004
- Impact of Age on the Outcome of Pulmonary Vein Isolation for Atrial Fibrillation Using Circular Mapping Technique and Cooled‐Tip Ablation Catheter:Journal of Cardiovascular Electrophysiology, 2004
- Role of the Posterior Left Atrium and Pulmonary Veins in Human Lone Atrial FibrillationCirculation, 2003
- Maintenance of sinus rhythm in patients with atrial fibrillation: An AFFIRM substudy of the first antiarrhythmic drugJournal of the American College of Cardiology, 2003
- A Comparison of Rate Control and Rhythm Control in Patients with Atrial FibrillationNew England Journal of Medicine, 2002
- Long-Term Efficacy of Amiodarone for the Maintenance of Normal Sinus Rhythm in Patients With Refractory Atrial Fibrillation or FlutterThe American Journal of Cardiology, 1995
- Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillationJournal of the American College of Cardiology, 1992
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989